市場調查報告書
商品編碼
1378802
獸醫診斷市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Veterinary Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球獸醫診斷市場規模達到61億美元。展望未來, IMARC Group預計到2028年市場規模將達到98億美元,2022-2028年複合年成長率(CAGR)為8.2%。飼養寵物的數量不斷增加,對寵物預防性護理的需求不斷增加,以及對可在動物和人類之間傳播的人畜共患疾病的認知不斷提高,是推動市場的一些主要因素。
獸醫診斷用於識別和診斷動物的疾病、損傷和其他健康狀況。它們對於為動物提供適當的醫療護理和製定有效的治療計劃至關重要。它們使獸醫能夠準確地識別影響動物的特定健康狀況或疾病。它們通常可以在臨床症狀明顯之前早期發現疾病。它們還提供有價值的資訊,幫助獸醫調整治療計劃並有效管理長期狀況。它們有助於識別動物中的人畜共通傳染病,從而採取適當措施控制這些疾病的傳播並保護動物和人類。
目前,由於世界各地寵物診所數量的增加,對獸醫診斷的需求不斷增加,正在推動市場的成長。除此之外,動物傳染病、慢性病和與年齡相關的疾病的日益流行也促進了市場的成長。此外,獸醫診斷技術的不斷進步提高了診斷測試的準確性、效率和速度,這提供了良好的市場前景。除此之外,獸醫學中對預防保健的日益重視正在支持市場的成長。此外,人們對人畜共通傳染病的認知不斷提高,這種疾病可以在人與動物之間傳播,這也促進了市場的成長。此外,越來越多的人願意為寵物投資先進的醫療護理,這也促進了市場的成長。
飼養寵物的數量不斷增加
目前,由於生活方式的改變、城市化以及人們對寵物陪伴帶來的健康益處的認知不斷增強,全球養寵物的數量不斷增加。寵物提供無條件的愛和忠誠,可以成為安慰和緩解壓力的來源。除此之外,寵物相關資源的可用性,如寵物商店、獸醫服務、寵物友善設施以及購買寵物用品的線上平台,使得養寵物變得更加容易和方便。此外,人們對動物福利的認知和關注不斷增強,在養寵物人數的增加中發揮重要作用。人們擴大從動物收容所和救援組織收養寵物,為被遺棄或忽視的動物提供更好的照顧。此外,隨著越來越多的人將寵物視為家庭成員,世界各地對獸醫診斷的需求正在增加。
先進診斷技術的不斷湧現
先進的診斷技術正在徹底改變獸醫診斷,能夠更準確、更有效地識別動物的疾病和健康狀況。它涉及對遺傳物質的分析,以檢測和識別特定的病原體、遺傳異常和疾病標記。除此之外,聚合酶鍊式反應 (PCR)、即時 PCR、脫氧核糖核酸 (DNA) 定序和微陣列等各種技術可以高靈敏度和特異性地檢測傳染源、遺傳性疾病和癌症突變。先進的獸醫診斷技術也可用於檢測複雜的骨折和腫瘤。它提供了大腦、脊髓、關節和軟組織結構的卓越視覺化。
提高對寵物預防性護理的認知
目前,人們對寵物預防性護理的認知有所提高,因為它可以改善動物的整體健康狀況並提高其存活率。除此之外,線上資源、網站、論壇和社交媒體平台為寵物主人提供有關預防措施、常規疫苗接種、健康檢查以及定期獸醫檢查重要性的資訊。反過來,這也使寵物主人能夠採取積極主動的措施來照顧他們的寵物。此外,獸醫診斷的進步有助於提高人們對預防性護理的認知和重要性。獸醫專業人員正在更了解疾病預防、疫苗接種計劃和定期篩檢的好處。他們可以向寵物主人提供有關預防性護理措施的教育,並提供基於證據的建議以保持寵物健康。
IMARC Group提供了全球獸醫診斷市場報告各細分市場主要趨勢的分析,以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據產品、技術、動物類型、疾病類型和最終用戶對市場進行了分類。
儀器
試劑盒和試劑
軟體和服務
試劑盒和試劑佔據市場主導地位
該報告根據產品提供了詳細的市場細分和分析。這包括儀器、套件和試劑以及軟體和服務。根據該報告,試劑盒和試劑佔據了最大的部分。
試劑盒和試劑在獸醫診斷中發揮著至關重要的作用,為各種診斷測試提供了必要的工具和物質。它們包括預先包裝的試劑和進行測試的說明,例如酶聯免疫吸附測定 (ELISA) 或聚合酶鏈反應 (PCR) 測定。這些試劑盒中的試劑旨在檢測特定病原體或疾病標記物,使獸醫能夠自發性、準確地診斷動物的傳染病。它們也用於測量參數,例如全血細胞計數、血液化學(包括肝功能和腎功能)、電解質水平和凝血能力。它們有助於檢測異常情況,例如細菌、寄生蟲、血液的存在或某些化學物質或代謝物的異常水平。
免疫診斷
臨床生物化學
分子診斷
血液學
其他
臨床生化市場佔有率最大
報告還提供了基於該技術的詳細市場細分和分析。這包括免疫診斷、臨床生物化學、分子診斷、血液學等。報告顯示,臨床生化佔據最大的市佔率。
臨床生物化學是獸醫診斷的基本組成部分,涉及分析血液和其他體液以評估動物的生理和生化狀態。它提供有關器官功能、代謝過程以及疾病或異常存在的有價值的資訊。它有助於測量各種參數,包括酵素、電解質、蛋白質、代謝物、荷爾蒙和廢物。它包括使用專門的實驗室設備和試劑進行的各種測試。它還專注於提供定量資料,幫助獸醫診斷、監測和治療各種病症。此外,透過評估血液中特定分析物的水平,如肝臟酵素、腎功能標記(肌酸酐)、葡萄糖、白蛋白和電解質(鈉和鉀),臨床生化有助於檢測器官功能障礙、營養失衡、動物內分泌失調和代謝異常。
伴侶動物
小狗
貓
其他
畜牧動物
牛
豬
家禽
其他
畜牧業佔最大市場佔有率
報告中還根據動物類型提供了詳細的市場區隔和分析。這包括伴侶動物(狗、貓等)和牲畜(牛、豬、家禽等)。報告稱,畜牧業(牛、豬、家禽等)佔據了最大的市場。
牲畜,如牛、豬、羊和家禽,需要獸醫診斷,因為它有助於有效地識別和診斷疾病。早期發現對於實施適當的控制措施以限制傳染病在牛群或羊群中的傳播至關重要。除此之外,診斷測試使獸醫能夠準確識別病原體,確定疾病流行程度,並指導實施有效的治療和預防策略。獸醫診斷測試也有助於評估個別動物和整個牛群或羊群的健康和生產力。透過監測血液化學、糞便品質和生長率等各種參數,獸醫可以識別和解決可能影響生產效率的健康問題,包括營養缺乏、寄生蟲感染、代謝紊亂和呼吸道疾病。
傳染性疾病
非傳染性疾病
遺傳性、先天性和後天性疾病
一般疾病
結構性和功能性疾病
非傳染性疾病佔大部分市場佔有率
報告還根據疾病類型對市場進行了詳細的細分和分析。這包括傳染病、非傳染性疾病、遺傳性、先天性和後天性疾病、一般疾病以及結構性和功能性疾病。報告顯示,非傳染性疾病佔了最大的市場。
獸醫診斷在識別動物傳染病方面發揮著至關重要的作用,因為準確、及時的診斷對於採取適當的治療和控制措施至關重要。它對於動物族群的疾病監測和監測至關重要。透過對個別動物或牛群或羊群進行診斷測試,獸醫可以評估傳染病的流行、傳播和影響。它還有助於識別動物中的各種人畜共患疾病,有助於預防或最大程度地減少病原體從動物到人類的傳播。透過診斷和管理動物傳染病,獸醫診斷有助於保護公眾健康並防止人畜共通感染的傳播。
參考實驗室
獸醫醫院和診所
其他
參考實驗室在市場中佔有最大佔有率
報告還提供了基於最終用戶的詳細市場細分和分析。這包括參考實驗室、獸醫醫院和診所等。報告稱,參考實驗室佔了最大的市場佔有率。
參考實驗室透過提供專業和先進的診斷服務來支持獸醫、診所和研究機構,在獸醫診斷中發揮著至關重要的作用。他們配備了最先進的技術、訓練有素的人員以及廣泛的獸醫診斷學科的專業知識。他們提供當地獸醫診所或實驗室可能無法提供的全面診斷測試。他們通常擁有更廣泛的測試選單,並且有能力執行需要專門設備、技術或專業知識的基本測試。參考實驗室可以進行高度特異性和敏感性的測試,以檢測傳染源、識別遺傳性疾病、診斷複雜疾病並評估動物的整體健康狀況。
北美洲
美國
加拿大
亞太地區
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
北美表現出明顯的主導地位,佔據最大的獸醫診斷市場佔有率
該報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。
由於獸醫專業實踐和轉診中心的增加,北美佔據了最大的市場佔有率。除此之外,對寵物健康和先進獸醫藥物的日益關注正在推動市場的成長。
另一個貢獻因素是對預防性醫療保健、早期疾病檢測和個人化治療方案的需求不斷成長,以確保他們的寵物過著長壽和健康的生活,這推動了市場的成長。
由於千禧世代擴大養寵物,預計亞太地區將在這一領域進一步擴張。除此之外,畜牧業和水產養殖業的不斷擴張也促進了市場的成長。
市場上的主要市場參與者正在實施各種策略和措施來改善其業務。他們投資於研發 (R&D) 活動,以創新和開發新的診斷技術、測試和產品。他們也致力於提高獸醫診斷測試的準確性、效率和速度,以及擴大可診斷的疾病和病症的範圍。頂尖公司正在積極尋求策略合作夥伴關係和收購,以擴大其產品供應、地理覆蓋範圍和市場佔有率。他們還為寵物主人提供遠距醫療服務,包括在某些場景下進行諮詢、監控和遠端診斷。領先的公司正在採用人工智慧 (AI)、機器學習 (ML) 和分子診斷來改善其產品供應和服務交付。
生物化學公司
生物梅里埃公司
赫斯卡公司
身份獸醫
IDEXX 實驗室公司
紐勤公司
朗道實驗室有限公司
賽默飛世爾科技公司
維克
碩騰公司
2020 年 4 月,BioChek BV 宣布成功收購 BIOTECON,打造獸醫和食品安全解決方案的新全球參與者。
2023 年 6 月,IDEXX Laboratories Inc. 宣布推出首個用於檢測貓狗腎損傷的獸醫診斷測試。
2023 年 4 月,瑪氏公司和 Heska Corporation 宣布簽署協議,瑪氏同意以每股 120 美元收購 Heska,從而擴大診斷和技術的覆蓋範圍,同時加速研發並擴大全球寵物醫療保健解決方案的覆蓋範圍。
The global veterinary diagnostics market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2022-2028. The growing number of pet ownerships, increasing demand for preventive care of pets, and rising awareness about zoonotic diseases, which can be transmitted between animals and humans, are some of the major factors propelling the market.
Veterinary diagnostics are used by veterinarians to identify and diagnose diseases, injuries, and other health conditions in animals. They are crucial for providing appropriate medical care and developing effective treatment plans for animals. They enable veterinarians to accurately identify the specific health condition or disease affecting an animal. They allow for early detection of diseases, often before clinical signs are evident. They also provide valuable information that helps veterinarians adjust treatment plans and manage long-term conditions effectively. They aid in identifying zoonotic diseases in animals, enabling appropriate measures to control the spread of these diseases and protect both animal and human populations.
At present, the increasing demand for veterinary diagnostics due to the rising number of pet clinics around the world is impelling the growth of the market. Besides this, the increasing prevalence of infectious diseases, chronic conditions, and age-related ailments in animals is contributing to the growth of the market. In addition, the growing technological advancements in veterinary diagnostics for improving the accuracy, efficiency, and speed of diagnostic tests are offering a favorable market outlook. Apart from this, the increasing emphasis on preventive healthcare in veterinary medicine is supporting the growth of the market. Additionally, the rising awareness about zoonotic diseases, which can be transmitted between humans and animals, is strengthening the growth of the market. Moreover, the increasing number of individuals who are willing to invest in advanced medical care for their pets is bolstering the growth of the market.
Rising number of pet ownerships
At present, there is a rise in the number of pet ownership worldwide, driven by changing lifestyles, urbanization, and the growing awareness about the health benefits associated with pet companionship. Pets offer unconditional love, loyalty, and can be a source of comfort and stress relief. Apart from this, the availability of pet-related resources, such as pet stores, veterinary services, pet-friendly establishments, and online platforms, for purchasing pet supplies, is making pet ownership more accessible and convenient. Moreover, the increasing awareness and concern about animal welfare is playing a significant role in the rise of pet ownership. People are increasingly adopting pets from animal shelters and rescue organizations, giving abandoned or neglected animals a better care. Furthermore, as more people consider their pets as family members, the demand for veterinary diagnostics is increasing around the world.
Increasing emergence of advanced diagnostic technologies
Advanced diagnostic technologies are revolutionizing veterinary diagnostics, enabling more accurate and efficient identification of diseases and health conditions in animals. It involves the analysis of genetic material to detect and identify specific pathogens, genetic abnormalities, and disease markers. Apart from this, various techniques, such as polymerase chain reaction (PCR), real-time PCR, deoxyribonucleic acid (DNA) sequencing, and microarrays, allow for the detection of infectious agents, genetic diseases, and cancer mutations with high sensitivity and specificity. Advanced veterinary diagnostic techniques are also useful for detecting complex fractures, and tumors. It provides superior visualization of the brain, spinal cord, joints, and soft tissue structures.
Increasing awareness about preventive care of pets
At present, there is an increase in awareness about preventive care of pets as it enhances the overall health conditions of animals and improves their survival rates. Apart from this, online resources, websites, forums, and social media platforms provide pet owners with information on preventive measures, routine vaccinations, wellness screenings, and the importance of regular veterinary check-ups. This, in turn, is empowering pet owners to take proactive measures in caring for their pets. Moreover, advancements in veterinary diagnostics are contributing to the awareness and importance of preventive care. Veterinary professionals are acquiring a better understanding of disease prevention, vaccination schedules, and the benefits of regular screenings. They can educate pet owners about preventive care measures and provide evidence-based recommendations for keeping pets healthy.
IMARC Group provides an analysis of the key trends in each segment of the global veterinary diagnostics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, technology, animal type, disease type and end user.
Instruments
Kits and Reagents
Software and Services
Kits and reagents dominate the market
The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments, kits and reagents, and software and services. According to the report, kits and reagents represented the largest segment.
Kits and reagents play a crucial role in veterinary diagnostics and provide essential tools and substances for conducting various diagnostic tests. They include pre-packaged reagents and instructions for conducting tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) assays. The reagents in these kits are designed to detect specific pathogens or disease markers, allowing veterinarians to diagnose infectious diseases spontaneously and accurately in animals. They are also used to measure parameters, such as complete blood counts, blood chemistries (including liver and kidney function), electrolyte levels, and blood clotting abilities. They assist in detecting abnormalities, such as the presence of bacteria, parasites, blood, or abnormal levels of certain chemicals or metabolites.
Immunodiagnostics
Clinical Biochemistry
Molecular Diagnostics
Hematology
Others
Clinical biochemistry holds the largest share in the market
A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, and others. According to the report, clinical biochemistry accounted for the largest market share.
Clinical biochemistry is a fundamental component of veterinary diagnostics that involves the analysis of blood and other body fluids to assess the physiological and biochemical status of animals. It provides valuable information about organ function, metabolic processes, and the presence of diseases or abnormalities. It helps measure a wide range of parameters, including enzymes, electrolytes, proteins, metabolites, hormones, and waste products. It encompasses various tests, which are conducted using specialized laboratory equipment and reagents. It also focuses on providing quantitative data that helps veterinarians in the diagnosis, monitoring, and treatment of various conditions. Furthermore, by evaluating the levels of specific analytes in the blood, such as liver enzymes, kidney function markers (creatinine), glucose, albumin, and electrolytes (sodium and potassium), clinical biochemistry aids in the detection of organ dysfunction, nutritional imbalances, endocrine disorders, and metabolic abnormalities in animals.
Companion Animals
Dogs
Cats
Others
Livestock Animals
Cattle
Swine
Poultry
Others
Livestock animals hold the maximum share of the market
A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animals (dogs, cats, and others) and livestock animals (cattle, swine, poultry, and others). According to the report, livestock animals (cattle, swine, poultry, and others) accounted for the largest market share.
Livestock animals, such as cattle, pigs, sheep, and poultry, require veterinary diagnostics as it helps identify and diagnose diseases effectively. Early detection is crucial for implementing appropriate control measures to restrict the spread of infectious diseases within herds or flocks. Besides this, diagnostic tests enable veterinarians to accurately identify the causative agents, determine the extent of disease prevalence, and guide the implementation of effective treatment and preventive strategies. Veterinary diagnostic testing also helps assess the health and productivity of individual animals and the overall herd or flock. By monitoring various parameters, such as blood chemistry, fecal quality, and growth rates, veterinarians can identify and address health issues that may affect production efficiency, including nutritional deficiencies, parasitic infections, metabolic disorders, and respiratory diseases.
Infectious Diseases
Non-infectious Diseases
Hereditary, Congenital and Acquired Diseases
General Ailments
Structural and Functional Diseases
Non-infectious diseases account for the majority of market share
A detailed breakup and analysis of the market based on the disease type have also been provided in the report. This includes infectious diseases, non-infectious diseases, hereditary, congenital, and acquired diseases, general ailments, and structural and functional diseases. According to the report, non-infectious diseases accounted for the largest market share.
Veterinary diagnostics play a crucial role in identifying infectious diseases in animals, as accurate and timely diagnosis is essential for appropriate treatment and control measures. It is essential for disease surveillance and monitoring in animal populations. By conducting diagnostic tests on individual animals or within herds or flocks, veterinarians can assess the prevalence, spread, and impact of infectious diseases. It also aids in identifying various zoonotic diseases in animals, helping prevent or minimize the transmission of pathogens from animals to humans. By diagnosing and managing infectious diseases in animals, veterinary diagnostics contribute to protect public health and prevent the spread of zoonotic infections.
Reference Laboratories
Veterinary Hospitals and Clinics
Others
Reference laboratories hold the largest share in the market
A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes reference laboratories, veterinary hospitals and clinics, and others. According to the report, reference laboratories accounted for the largest market share.
Reference laboratories play a vital role in veterinary diagnostics by providing specialized and advanced diagnostic services to support veterinarians, clinics, and research institutions. They are equipped with state-of-the-art technology, highly trained personnel, and expertise in a wide range of veterinary diagnostic disciplines. They offer a comprehensive number of diagnostic tests that may not be available at local veterinary clinics or laboratories. They often possess a broader test menu and the capacity to perform essential tests that require specialized equipment, techniques, or expertise. Reference laboratories can perform highly specific and sensitive tests to detect infectious agents, identify genetic disorders, diagnose complex diseases, and assess the overall health status of animals.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest veterinary diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
North America held the biggest market share due to the increase in veterinary specialty practices and referral centers. Besides this, the rising focus on pet health and wellness and advanced veterinary medicine is propelling the growth of the market.
Another contributing aspect is the increasing demand for preventive healthcare, early disease detection, and personalized treatment options to ensure their pets lead long and healthy lives is propelling the growth of the market.
Asia Pacific is estimated to expand further in this domain due to rising adoption of pets among millennials. Besides this, the increasing expansion of livestock and aquaculture industries is bolstering the growth of the market.
Key market players in the market are implementing various strategies and initiatives to improve their business. They are investing in research and development (R&D) activities to innovate and develop new diagnostic technologies, tests, and products. They are also focusing on improving the accuracy, efficiency, and speed of veterinary diagnostic tests, as well as expanding the range of diseases and conditions that can be diagnosed. Top companies are actively pursuing strategic partnerships and acquisitions to expand their product offerings, geographical reach, and market share. They are also providing telemedicine services to pet owners, comprising of consultation, monitoring, and remote diagnostic in certain scenarios. Leading companies are embracing artificial intelligence (AI), machine learning (ML), and molecular diagnostics to improve their product offerings and service delivery.
BioChek B.V.
Biomerieux SA
Heska Corporation
IDvet
IDEXX Laboratories Inc.
Neogen Corporation
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
Virbac
Zoetis Inc.
In April 2020, BioChek B.V. announced the successful acquisition of BIOTECON to create a new global player in veterinary and food safety solutions.
In June 2023, IDEXX Laboratories Inc. announced the launch the first veterinary diagnostic test of for detecting kidney injury in cats and dogs.
In April 2023, Mars, Incorporated and Heska Corporation announced that they had entered into an agreement under which Mars agreed to acquire Heska for $120.00 per share, enabling broader coverage across diagnostics and technology, while accelerating R&D and expanding access globally to pet healthcare solutions.